In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

NCI Drug Dictionary

  

robatumumab 
A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Robatumumab binds to membrane-bound IGF-1R, preventing binding of the ligand IGF-1 and the subsequent triggering of the PI3K/Akt signaling pathway; downregulation of this survival pathway may result in the induction of apoptosis and decreased cellular proliferation. The activation of IGF-1R, a tyrosine kinase and a member of the insulin receptor family, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been highly implicated in tumorigenesis and metastasis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:anti-IGF-1R recombinant monoclonal antibody SCH 717454
Code name:SCH 717454
Chemical structure:immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal SCH 717454 heavy chain), disulfide with human monoclonal SCH 717454 light chain, dimer